TMPRSS2 and COVID-19: The rationale for their use is based on the blockage of conversion of testosterone into 5alplha-DHT and mitigation of TMPRSS2 expression [128–130], eventually hampering the overrepresentation of males, particularly bald ones, in severe COVID-19.